This study evaluates the relationship between obstructive sleep apnea (OSA) and asthma. Literature search was carried out in several electronic databases and random effects meta-analyses were performed to obtain pooled estimates of the prevalence of OSA, OSA risk and sleep disordered breathing (SDB) in asthma patients and pooled odds ratios of the prevalence between asthma and nonasthma patients. In adult asthma patients, the prevalence [95% confidence interval] of OSA, OSA risk, and SDB was 49.50 [36.39, 62.60] %, 27.50 [19.31, 35.69] %, and 19.65 [14.84, 24.46] % respectively. The odds of having OSA, OS risk and SDB by the asthma patients were 2.64 [1.76, 3.52], 3.73 [2.90, 4.57] and 1.73 [1.11, 2
Inclusion and exclusion criteria. Inclusion criterion was: clinical or epidemiological studies which examined the relationship between asthma and sleep disorders and reported the prevalence of OSA or OSA risk or SDB in asthma patients. Studies were excluded from the meta-analysis if reported only the sleep quality measures other than OSA, OSA risk or SDB, or provided qualitative information only.
Literature search. Electronic Primary and secondary endpoints. Primary endpoints were: a) the prevalence of OSA (diagnosed with sleep studies only), OSA risk (a valid questionnaire-based evaluation) and SDB (one or more abnormal breathing and/or gas exchange patterns during sleep including habitual loud snoring at least 3-4 times/week, ≥3% desaturation/hour, upper airway resistance syndrome, and central sleep apnea) in asthma patients; and b) the pooled effect size of the odds ratios of the prevalence of OSA/OSA risk/SDB between asthma and non-asthma patients. Secondary endpoints were mean differences in BMI, % predicted FEV, and ESS score between asthma patients with OSA/OSA risk/SDB and without OSA/OSA risk/SDB.
Data extraction, synthesis and statistical analyses. Important information including outcome meas-
ures and outcomes, primary and secondary endpoints, participants' demographic and clinical characteristics and other relevant information were obtained from the selected research articles of the respective studies and organized on datasheets. Data were extracted by two researchers independently who later cross checked the work of each other. Inter-rater reliability was good (kappa = 0.94).
Random effects meta-analyses were performed with STATA software (version 12; Stata Inc. Texas, USA) to achieve overall effect sizes of the prevalence of OSA, OSA risk, and SDB in asthma patients and to achieve a summary estimate of the odds ratio of the prevalence of OSA/OSA risk/SDB between asthma and non-asthma patients observed in the individual studies.
To assess the significance of differences in FEV (% predicted), BMI and ESS between asthma patients with and without OSA/OSA risk/SDB, meta-analyses of mean differences were carried out with RevMan software (version 5.3.5; Cochrane Collaboration) under random effects model. Between studies statistical heterogeneity was tested by tau 2 and I 2 indices.
Results
Data were acquired from 26 studies (7675 patients) which fulfilled the eligibility criteria ( Fig. 1 ). Important characteristics of the included studies are presented in Table S1 . Average age of adult asthma patients was 48.9 ± 10 (range 42 ± 11 to 58.4 ± 15) years and that of asthmatic children 7.45 ± 3.2 (range 6.4 ± 4.4 to 9.1 ± 3.4) years. Proportion of males in this sample population was 41 ± 15% in adults and 62 ± 5.6% in children.
In adult asthma patients, the prevalence of OSA was 49.50 [ ; p < 0.00001 (respectively) times higher in asthma patients than in non-asthma patients (Fig. 3 ).
Adult patients with asthma and OSA had significantly higher BMI than the asthma patients without OSA (mean difference: 2.15 [3.64, 0.67] kg/m 2 ; p = 0.004; Fig. 4 ). In children, BMI z scores did not differ between asthma-OSA and non-asthma OSA patients. However, the number of included studies was less in this analysis (Fig. 4) .
Although, there was no significant difference between the asthma patients with and without OSA in percent predicted FEV (mean difference: −2.28 [−6.79, 2.23] %; p = 0.32; Figure S1 ), the Epworth sleep scale score was significantly higher in the asthma patients with OSA (mean difference: 3.98 [1.30, 6.66]; p = 0.004; Figure S2 ) in comparison with non-OSA asthma patients.
Discussion
This meta-analysis has revealed that the prevalence of OSA, OSA risk and SDB in adult asthma patients is 50%, 27.5% and 20%, respectively, and the odds of having OSA, OSA risk and SDB is 2.64, 3.73, and 1.73 times higher (significantly) in asthma patients than in non-asthma patients. Asthma patients with OSA also had significantly higher BMI in comparison with non-asthma patients.
Both asthma and OSA have airway obstruction in the pathogenesis and have many diurnal and nocturnal symptoms in common 48 . Obstructive sleep apnea is identified as an independent risk factor for asthma exacerbation 40 , and OSA is reported to be more prevalent among patients with severe asthma than in moderate asthma which may be linked to the potential pathophysiologic interaction between OSA and asthma severity 30 . Moreover, a significant alleviation in asthma symptoms has been reported with the long-term use of continuous positive air pressure (CPAP) in patients with both asthma and OSA 49, 50 . Obesity and related comorbidities, including SDB and gastro-esophageal reflux are found to be highly prevalent in asthma patients in many epidemiological studies 31, 35, 51 . A high body mass index may be a worsening factor in both conditions 52 . Although, obesity is a well-recognized risk factor for asthma in adult patients, but a causal relationship is still lacking 53 . There is also some evidence to suggest that hypothyroidism may also play a role in obesity mediated OSA severity 54 .
An important aspect that needs to be further studied is the association between AHI and asthma severity. In the included studies of present meta-analysis, some observations indicate that there exists a positive relationship between SDB and asthma severity e.g. Goldstein et al. 27 mentioned that percentage of snoring patients was 33%, 38%, and 43% in mild, moderate, and severe asthma patients, respectively. Ross et al. 35 also found that percentage of patients with snoring and desaturation was higher in severe asthma (55%) than in moderate asthma (20%) patients. Julien et al. 30 found that sleeping efficiency and arousal index were significantly higher in severe than in moderate asthma patients. Zidan et al. 47 found that percentage of OSA-asthma patients was 5.6% in well-controlled asthma patients, 61% in partially controlled and 33.3% in uncontrolled asthma patients.
Based on the above-mentioned findings, it can be presumed that the relationship between OSA and asthma have therapeutic implications. Effective treatment of OSA can favorably impact asthma control; CPAP is one such treatment 49, 50 . The CPAP therapy is also found to reduce gastroesophageal reflux disease and inflammation in OSA patients which may be beneficial for both asthma and OSA. However, CPAP has also been reported to increase bronchial hyper-responsiveness in non-asthma OSA patients 55, 56 and cause sleep abnormalities in non-OSA asthma patients 57 which makes it necessary to further investigate the effectiveness and consequences of this therapy.
Asthma-OSA overlap appears to be an area where patient-centered healthcare is more important because not only asthma is associated with significantly more comorbidities in comparison with other diseases 58 but it is also evident that OSA has relationship with obesity and hypothyroidism 54 . Therefore, consideration of relevant therapies may have better impact e.g. bariatric surgery is found to be associated with improvement in symptoms of OSA and asthma 37 . Vitamin D deficiency has been reported to be associated with OSA severity 59 and vitamin D treatment in asthma patients is found to reduce exacerbations 60 . Thus, it seems imperative that while managing asthma patients, physicians should examine the symptoms suggestive of OSA and consider differential diagnostics, especially in unstable, under-controlled and overweight patients that may also help in choosing a therapeutic strategy.
Conclusion
The prevalence of OSA in adult asthma patients is estimated at 50% in this meta-analysis and the odds of having OSA is 2.64 times higher in asthma patients than in the non-asthma patients. Moreover, the prevalence of OSA risk and SDB are estimated at 27.5% and 20% respectively. The odds of having OSA risk and SDB is 3.73 and 1.73 time higher (respectively) in asthma patients than in non-asthma patients. The prevalence of OSA was higher than the prevalence of SDB in asthma patients which indicates the existence of a bilateral relationship between OSA and asthma to result in a more severe phenotype. Asthma patients with OSA also had significantly higher BMI in comparison with non-OSA asthma patients. Therefore, a closer look at the symptoms suggestive of OSA is necessary in asthma patients especially in more severe forms and overweight individuals.
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